Home / Cannabis / Business / Some CBD Products May Be a Rip-Off for Medical Marijuana Users, Study Finds
Dropper With Liquid Stock Photo

Some CBD Products May Be a Rip-Off for Medical Marijuana Users, Study Finds

Cannabidiol, a major component of marijuana, is in high demand these days for its purported health benefits. But a study published on Tuesday discovered that people trying to treat themselves with cannabidiol products likely aren’t getting what they’re paying for.

Carter Sherman | VICE News

The study, led by the University of Pennsylvania, tested 84 cannabidiol products purchased online from 31 companies and found that less than a third were properly labeled. Nearly 43 percent of the products — which included oils, tinctures, and vaporization liquid — contained less cannabidiol than their labels promised, indicating that they weren’t potent enough to give their users the medicinal treatment they sought. Another 26 percent of the products contained more.

RELATED: California Cities Prepare for Impact of Legal Cannabis Industry

There’s no evidence that taking too much cannabidiol is dangerous, and you can’t get high off cannabidiol alone. (Scientists are also split over cannabidiols’ medicinal use, though some studies indicate it can help with chronic pain.) But THC was also found in about 21 percent of the products in the study. That may be an even bigger issue for unsuspecting users, since the researchers note that “the THC content observed may be sufficient to produce intoxication or impairment, especially among children.”

The federal government classifies cannabidiol as a Schedule I drug, just like marijuana. Twenty-nine states permit people to use marijuana for medicinal purposes, and eight allow recreational marijuana use. Researchers blame the labeling issues on these discrepancies and the ensuing lack of regulation.

“As there is currently no systematic oversight of this industry from the FDA, it means that it is up to the consumer to test their products to assure that they know what is in their medicine,” Marcel Bonn-Miller, an adjunct assistant professor at the University of Pennsylvania Perelman School of Medicine who led the study, told Tonic.

Inaccurate labeling in the marijuana industry, however, isn’t just a problem when it comes to cannabidiol. A VICE News investigation in June found that, thanks to a lack of testing and strict standards between states, the THC content on some marijuana products is also mislabeled.

Read the full story from VICE News

Read more cannabis-related stories at LedeTree

Header photo: news.lift.co

About Carter Sherman

Carter Sherman
Carter is a freelance, generalist journalist currently based in Seattle, Washington. She has previously served as the Voice Media Group Fellow at the Houston Press, reporting on everything from Black Lives Matter to anime. Her work has also appeared in ELLE Magazine, Ms. Magazine, and Los Angeles magazine.

Check Also

Aurora Cannabis Logo

Coke and Cannabis: Coca-Cola in Talks With Aurora

The Coca-Cola Co. is in “serious talks” with Aurora Cannabis Inc. to develop cannabis-infused beverages, …

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.